<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib82">
 <label>82</label>
 <element-citation publication-type="journal" id="sref82">
  <person-group person-group-type="author">
   <name>
    <surname>Chen</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Gong</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>First clinical study using HCV protease inhibitor danoprevir to treat naive and experienced COVID-19 patients</article-title>
  <source>MedRxiv</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1101/2020.03.22.20034041</pub-id>
 </element-citation>
</ref>
